Abbott India Ltd share price logo

Abbott India Ltd Share Price (ABBOTINDIA)

Check the latest share price of Abbott India Ltd, along with the price target, peer comparison, quarterly results, recent news, expert analysis, shareholding pattern, and other key fundamentals to make informed investment decisions.

₹343900.67%

as on 04:01PM, 09 Jul 2025

NSE

bell
The current prices are delayed by 15 mins, login to check live prices.

Abbott India Ltd Stock Performance

Get live Abbott India Ltd share price, day's high and low, historical returns, and market stats.

  • Day's Low

    Day's High

    ₹34,000
    Day's Price Range
    ₹34,600
  • 52 Week's Low

    52 Week's High

    ₹25,325
    52-Week Price Range
    ₹37,000
1 Month Return+ 7.39 %
3 Month Return+ 17.36 %
1 Year Return+ 20.55 %
3 Year Return+ 76.59 %
5 Year Return+ 119.7 %
Previous Close₹34,160.00
Open₹34,250.00
Volume10.34K
Upper Circuit₹40,990.00
Lower Circuit₹27,330.00

Abbott India Ltd Fundamentals & Key Indicators

Check Abbott India Ltd market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

₹72,590.00 Cr

Return on Equity (ROE)

34.88

PE Ratio (TTM)

0

Return on capital employed (ROCE)

44.71

Beta (LTM)

0.49

P/B Ratio

15.48

Dividend Yield

0

PEG Ratio

0

Quarterly Earnings Growth YOY

27.86

EPS (TTM)

35.67

Sector

Pharmaceuticals

Book Value

106.54

Technical Analysis

How to invest in Abbott India Ltd?

Investing in Abbott India Ltd is simple. You can open a free INDstocks investment account on the INDmoney App. Search for Abbott India Ltd or ABBOTINDIA on the app to check live prices of the stock and click on Buy or SIP. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

For example: You can buy 10 shares of Abbott India Ltd or start an SIP based on the market price on each investment date.
You can easily transfer money to your stock account via the INDmoney app and start investing in stocks like Abbott India Ltd with just a few clicks!

Abbott India Ltd Stock's Interest Amongst Investors

52%

Period Jul 09, 2025 to Jun 09, 2025. Change in 30 Days vs previous period

Search interest for Abbott India Ltd Stock has increased by 52% in the last 30 days, reflecting an upward trend in search activity.

Abbott India Ltd Stock Recommendation

Get updated buy, sell, and hold recommendations by analysts on Abbott India Ltd.

based on 8 analysts

BUY

87.50%

Buy

0.00%

Hold

12.50%

Sell

87.5% of analysts recommend a 'BUY' rating for Abbott India Ltd. Average target price of ₹33417.5

Source: S&P Global Market Intelligence

Abbott India Ltd Share Price Target

Get share price movements and forecasts by analysts on Abbott India Ltd.

Abbott India Ltd price forecast by 8 analysts

Downside of-2.17%

High

₹35750

Target

₹33417.50

Low

₹28500

Abbott India Ltd target price ₹33417.5, a slight downside of -2.17% compared to current price of ₹34390. According to 8 analysts rating.

Source: S&P Global Market Intelligence

Abbott India Ltd Financial Results

Get the annual and quarterly financial summary of Abbott India Ltd, including revenue, profit, loss and more.

Value in ₹ crore
DetailsQ4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25
Revenue

(in ₹ Cr)

1439 (0%)1558 (8%)1633 (5%)1614 (1%)1605 (1%)
Net Income

(in ₹ Cr)

287 (0%)328 (14%)359 (9%)361 (1%)367 (2%)
Net Profit Margin19.95% (0%)21.06% (6%)21.96% (4%)22.35% (2%)22.87% (2%)
Value in ₹ crore
DetailsFY21FY22FY23FY24
Total Assets

(in ₹ Cr)

3850 (0%)4233 (10%)4564 (8%)5202 (14%)
Total Liabilities

(in ₹ Cr)

1248 (0%)1413 (13%)1375 (3%)1503 (9%)
Value in ₹ crore
DetailsFY20FY21FY22FY23FY24
Operating Cash Flow

(in ₹ Cr)

626 (0%)727 (16%)948 (30%)893 (6%)1213 (36%)

Indices Featuring Abbott India Ltd Stock

Check stock indices that include Abbott India Ltd.

Nifty Healthcare

₹14,534.90

-0.36 (-53.2%)

Nifty MNC

₹29,026.70

0.21 (62.1%)

S&P BSE 150 MidCap

₹16,260.07

0.01 (1.08%)

S&P BSE Low Volatility

₹1,875.17

0.18 (3.34%)

BSE 200

₹11,561.13

-0.18 (-20.28%)

BSE Healthcare

₹44,480.38

-0.08 (-34.66%)

Nifty LargeMidcap 250

₹16,513.15

-0.1 (-16.15%)

BSE Mid-Cap

₹46,723.58

-0.05 (-24.83%)

S&P BSE 250 LargeMidCap

₹10,963.93

-0.16 (-17.57%)

S&P BSE 400 MidSmallCap

₹12,321.85

0.17 (21.48%)

S&P BSE Quality

₹1,878.84

0.09 (1.71%)

BSE 500

₹36,963.79

-0.1 (-35.23%)

NIFTY PHARMA

₹22,208.50

0.19 (42.6%)

Nifty Midcap 150

₹21,878.65

-0.03 (-7.5%)

Nifty MidSmallcap 400

₹20,433.65

0.17 (35.6%)

Nifty 500

₹23,557.45

-0.06 (-15.1%)

Abbott India Ltd Earnings and Dividends

View detailed summary of the earnings and dividend history of Abbott India Ltd.

  • Abbott India Ltd Earnings Results

    Abbott India Ltd’s net profit jumped 27.86% since last year same period to ₹367.04Cr in the Q4 2024-2025. On a quarterly growth basis, Abbott India Ltd has generated 1.74% jump in its net profits since last 3-months.

    Read More about Earnings Results
  • Abbott India Ltd Dividends May,2024

    In the quarter ending March 2024, Abbott India Ltd has declared dividend of ₹410.00 - translating a dividend yield of 2.13%.

    Read More about Dividends

Abbott India Ltd Shareholding Pattern

View the shareholding pattern breakup of promoters, FIIs, DIIs, and retail investors in Abbott India Ltd.

InvestorsHoldings %Quarterly Trend3M change
Promoter Holdings
74.99%
0.00
Foreign Institutions
0.16%
0.00
Mutual Funds
7.73%
0.00
Retail Investors
15.93%
0.00
Others
1.19%
0.00

Abbott India Ltd vs Peers

Compare market cap, revenue, PE, and other key metrics of Abbott India Ltd with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
BUY72,590.0023.94%0.53NANA
BUY13,842.18-4.18%0.524132,013
BUY67,248.178.24%0.563,16829,001
HOLD98,932.9335.23%0.643,85419,547
BUY55,238.2324.23%0.569273,749

Abbott India Ltd News & Key Events

Latest news and events in one place to help you make informed investing decisions in Abbott India Ltd.

  • Abbott India Declares Record Dividend of Rs 475 - 30 Jun, 2025

    Abbott India has announced a record final dividend of Rs 475 per share for FY 2024-25, subject to shareholder approval. The record date is set for July 25, 2025, with payment expected after August 18, 2025. This marks the second time the company has declared a dividend exceeding Rs 400 per share.
  • Abbott India Reaches All-Time High Stock Price - 26 Jun, 2025

    Abbott India shares achieved an all-time high of Rs 32,330, showcasing strong investor confidence and a positive outlook on the company's performance.
  • Abbott Enters Strategic Agreement with MSD Pharmaceuticals - 18 Jun, 2025

    Abbott India has signed a strategic distribution agreement with MSD Pharmaceuticals to promote sitagliptin-based anti-diabetes medications in India, leveraging Abbott's distribution network. This partnership aims to improve access to effective diabetes treatments amid rising competition from generics.
  • Abbott India Shares Reach All-Time High - 06 Jun, 2025

    Abbott India shares hit an all-time high of Rs 31,999.35 on the BSE, reflecting strong investor confidence and positive market sentiment. The stock's performance indicates consistent growth in financial metrics, with a bullish outlook for the company.

Insights on Abbott India Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Retail Holding Up

    img

    Retail Investor have increased holdings from 15.84% to 15.93% in Mar 2025 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Divis Laboratories Ltd has given 52.4% return, outperforming this stock by 31.9%

  • imgNO EFFECT

    FII Holding Unchanged

    img

    Foreign Institutions holdings remained unchanged at 0.16% of holdings in Mar 2025 quarter

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 74.99% of holdings in Mar 2025 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Torrent Pharmaceuticals Ltd has given 123.9% return, outperforming this stock by 47.3%

  • imgNEGATIVE IMPACT

    MF Holding Down

    img

    Mutual Funds have decreased holdings from 7.77% to 7.73% in Mar 2025 quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, ABBOTINDIA stock has moved down by -3.7%

About Abbott India Ltd

Abbott India Ltd is a leading multinational pharmaceutical company in India, with its headquarters in Mumbai. It has manufacturing facilities in Goa and independent contract/third party manufacturers based across the country. The company provides products and solutions across therapeutic areas such as Womens Health, Gastroenterology, Central Nervous System, Metabolics, MultiSpecialty, Vaccines and Consumer Health. In 2002, they sold their Jejuri Undertakings with assets and liabilities as a going concern. In 2003, they amalgamated Knoll Pharmaceuticals Ltd with the company. In 2004, they started capsule production with a capacity of 27 million nos. and in 2005, they further increased the capacity to 56 million nos. and started a new project of producing nutritional products with installed capacity of 600 tonnes. In 2006, the production capacity of Tablets was also increased by 236 million nos to 686 million. In 2008, they launched Digene Total buffered pantoprazole tablet, Bruge, and Thyronorm 150 Digene along with Sugar Free Tablet and Gel. In 2018, Abbott India Ltd formed a new Business Unit GI Advance which followed a Build Operate Transfer model. During the year 2020-21, the company made an innovation in Brufen Coating formula leading to 50% increase in coating installed capacity. It further executed 8 new studies and published 8 articles in major indexed journals. Abbott India also launched 10 new products in various therapy segments leading to their recognition as The Most Innovative MNC of the Year 2019 at the 12th Pharma Leaders Award. The Drug Price Control Order 2013 brought several products of Abbott India under price control, leading to an adverse impact on sales and profits. They also received approvals to conduct phase 3 studies in adults/eldery and pediatric for their Influvac Quadrivalent Vaccine QIV Program. Abbott India has been making continuous efforts for portfolio expansion launching unique products and leveraging technology for better healthcare outcomes.

Revenue: ₹1,604.59Cr as on March 2025 (Q4 FY25)
Net Profit: ₹367.04Cr as on March 2025 (Q4 FY25)
Listing date: 03 Nov, 1994
Chairperson Name: Munir Shaikh
OrganisationAbbott India Ltd
HeadquartersMumbai
IndustryPharmaceuticals
CEOMunir Shaikh
E-voting on sharesClick here to vote

Mutual Funds that own Abbott India Ltd

Check out the Mutual Funds with significant holdings in Abbott India Ltd.

FAQs

What is Abbott India Ltd share price today?

Abbott India Ltd share price today stands at ₹34390, Open: ₹34250, Previous Close: ₹34160, High: ₹34600, Low: ₹34000, 52 Week High: ₹37000, 52 Week Low: ₹25325.

What is today's traded volume of Abbott India Ltd?

Today's traded volume of Abbott India Ltd is 10.34K. Which means that 10.34K shares of Abbott India Ltd were bought and sold on the stock market during today's trading session.

What is Abbott India Ltd's market cap today?

Today's market capitalisation of Abbott India Ltd is ₹72,590.00 Cr. Market cap or market capitalisation is the total value of a company’s outstanding shares in the stock market, calculated by multiplying the current share price by the total number of shares issued by the company.

What is the 52 week high and 52 week low range of Abbott India Ltd?

Abbott India Ltd’s 52 week high is ₹37000 and 52 week low is ₹25325. The current share price of Abbott India Ltd is ₹34390, which is -7.05% down from its 52 week high and 35.79% up from its 52 week low.